Welcome to our dedicated page for IX Acquisition news (Ticker: IXAQ), a resource for investors and traders seeking the latest updates and insights on IX Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect IX Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of IX Acquisition's position in the market.
Summary not available.
Summary not available.
On March 23, 2023, IX Acquisition Corp. (NASDAQ: IXAQ) announced the filing of a definitive proxy statement with the SEC to seek shareholder approval for a 12-month extension to finalize its initial business combination, moving the deadline from April 12, 2023, to April 12, 2024. Each month of extension requires the sponsor to deposit $160,000 or $0.04 per public share into a trust account, potentially overfunding it by $1,920,000. The meeting for votes is scheduled for April 10, 2023. Additionally, as a Cayman Islands company, any share redemptions will not be subject to the Excise Tax established by the Inflation Reduction Act of 2022.
IX Acquisition Corp. has successfully closed its IPO, issuing 23 million units at $10 each, including 3 million from the underwriters’ over-allotment option. The company began trading on Nasdaq under the symbol IXAQU on October 7, 2021. Each unit comprises one Class A ordinary share and a half redeemable warrant, with full warrants priced at $11.50. IX Acquisition Corp. focuses on merging with companies in the Technology, Media, Telecommunications, and Information sectors, particularly in Europe and emerging markets.
IX Acquisition Corp. announced the pricing of its initial public offering (IPO) of 20,000,000 units at $10.00 each, set to list on Nasdaq under the ticker symbol 'IXAQU' from October 7, 2021. Each unit comprises one Class A ordinary share and half a redeemable warrant, with each whole warrant at $11.50 per share. The IPO is expected to close on October 12, 2021. Led by CEO Karen Bach, the company plans to focus on business combinations in the Technology, Media, and Telecommunications sectors, particularly in Europe and emerging markets.